These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 200511)

  • 1. Hormone receptors: VI. On the nature of the binding of glucagon and insulin to human circulating mononuclear leukocytes.
    Blecher M; Goldstein S
    Mol Cell Endocrinol; 1977 Oct; 8(4):301-15. PubMed ID: 200511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone receptors, 5. Binding of glucagon and insulin to human circulating mononuclear cells in diabetes mellitus.
    Goldstein S; Blecher M; Binder R; Perrino PV; Recant L
    Endocr Res Commun; 1975; 2(4-5):367-76. PubMed ID: 171138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon.
    Bhathena SJ; Louie J; Schechter GP; Redman RS; Wahl L; Recant L
    Diabetes; 1981 Feb; 30(2):127-31. PubMed ID: 6110596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man.
    Schwartz RH; Bianco AR; Handwerger BS; Kahn CR
    Proc Natl Acad Sci U S A; 1975 Feb; 72(2):474-8. PubMed ID: 164655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-specific binding to human peripheral blood monocytes and polymorphonuclear leukocytes.
    Chabaud O; Lissitzky S
    Mol Cell Endocrinol; 1977 Mar; 7(1):79-87. PubMed ID: 192614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostaglandin E1 and prostaglandin F2alpha on insulin and glucagon plasma levels during the intravenous glucose tolerance test in man.
    Giugliano D; Torella R; Improta L; D'Onofrio F
    Diabete Metab; 1978 Sep; 4(3):187-91. PubMed ID: 710679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of glucagon receptors on T- and B- lymphoblasts: comparison with insulin receptors.
    Bhathena SJ; Gazdar AF; Schechter GP; Russell EK; Soehnlen FE; Gritsman A; Recant L
    Endocrinology; 1982 Aug; 111(2):684-92. PubMed ID: 6284489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the fibronectin receptors of human peripheral blood leukocytes. Morphologic and functional characterization.
    Pommier CG; O'Shea J; Chused T; Yancey K; Frank MM; Takahashi T; Brown EJ
    J Exp Med; 1984 Jan; 159(1):137-51. PubMed ID: 6319529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon degradation by human mononuclear cells.
    Neal GW; Solomon SS; Shankar TP; Duckworth WC
    Diabetologia; 1983 Nov; 25(5):404-10. PubMed ID: 6317504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and glucagon binding to hepatocytes in relation to circulating hormones and metabolites in goats maintained on different diets.
    Gill RD; Hart IC
    Horm Metab Res; 1981 Nov; 13(11):603-9. PubMed ID: 6273275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced regulation of insulin receptor affinity: role of circulating metabolites.
    Michel G; Schwarz W; Bieger WP
    Int J Sports Med; 1985 Apr; 6(2):100-6. PubMed ID: 2861168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha-and beta-adrenergic inhibition and somatostatin on plasma glucose, free fatty acids, insulin glucagon and growth hormone responses to prostaglandin E1 in man.
    Giugliano D; Torella R; Sgambato S; D'Onofrio F
    J Clin Endocrinol Metab; 1979 Feb; 48(2):302-8. PubMed ID: 429484
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.
    Tse TF; Clutter WE; Shah SD; Miller JP; Cryer PE
    J Clin Invest; 1983 Jul; 72(1):270-7. PubMed ID: 6409929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro regulation of human monocyte insulin receptors by insulin and 1-methyl-3-isobutylxanthine.
    Whitson RH; Kaplan SA
    Am J Physiol; 1983 Nov; 245(5 Pt 1):E494-501. PubMed ID: 6195925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin binding, insulin degradation and glucose metabolism in human monocytes.
    Beck-Nielsen H; Pedersen O
    Diabetologia; 1979 Aug; 17(2):77-84. PubMed ID: 488569
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased insulin binding to monocytes after acute exercise in normal man.
    Soman VR; Koivisto VA; Grantham P; Felig P
    J Clin Endocrinol Metab; 1978 Jul; 47(1):216-9. PubMed ID: 400712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
    Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
    Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.